CalciMedica, a San Diego biotech focused on autoimmune and inflammatory disease, raised $1.53 million in a first funding round, PE Hub reports, citing a regulatory filing. S.R. One provided the funding.
Tags: autoimmune-disease, biotechnology, co:CalciMedica, deal, inflammation, inv:S.R.-OneTop Stories
- Meraki brings free WiFi to 100,000 San ...
- Miasole perhaps not so unhealthy after all ...
- Google Talk comes to the iPhone. Death ...
- The Roku box to expand beyond Netflix. ...
- Microsoft Office makes bold leap into online ...
Featured Guest Columnists
- David Gal
Is Facebook’s Platform a strategic mistake? - Richard Wong
View from Barcelona: The end of the operator-dominated era? - Bernard Moon
U.S. tech trends for 2008
Job Board
- Director, Business Development
at MySpace (San Francisco, CA, USA) - Sr. SW Engineer - Eclipse Plug-in/RCP
at Silver Key, Inc. (Mountain View, CA) - Product Marketing Manager â Wireless LAN
at Silver Key (Santa Clara) - More Jobs » | Post a Job »
Links
Venturebeat Writers
- Matt Marshall, Editor-in-Chief
- Dean Takahashi, Lead Writer, DigitalMedia
- Eric Eldon, Editor, DigitalMedia
- David Hamilton, Editor, LifeScience
- MG Siegler, Writer, DigitalMedia
- Anthony Ha, Writer, VentureBeat
- Chris Morrison, Writer, CleanTech
- For advertising, contact .
- Log in
Font Size
© 2004-2008(c) Matt Marshall. All rights reserved.Site produced by RubyRed Labs, Evan Levelle
powered by Wordpress
3:38 pm
VentureBeat » Life sciences briefing: Tuesday, Feb. 12, 2008 said:
[...] CalciMedica raises $5.5M for autoimmune drugs – San Diego’s CalciMedica, a biotech developing drugs for immune-related conditions, raised $5.5 million in a second funding round, VentureWire reports. Investors included Sanderling Ventures and SR One. We previously noted the startup’s first funding round here. [...]